Standard Panel of Sera Containing and Not Containing HIV-1/2 Antibodies for Assessing the Quality of Clinical Diagnostic Laboratories

This tender concerns the procurement of a standard panel of sera, which includes samples both positive and negative for HIV-1/2 antibodies. The primary purpose of this panel is to serve as a quality control material for evaluating the performance of clinical diagnostic laboratories. This is crucial for ensuring the accuracy and reliability of HIV testing within these facilities.

The procurement falls under the national classification codes NK 024:2023 48456 for HIV-1/HIV-2 antibodies (in vitro diagnostics, IVD) and control materials, and NK 031:2024 6125/ W0105080804 for other virology control materials. The specific item required is a standard panel of sera containing and not containing HIV-1/2 antibodies, identified by catalog number P-01-Q1-0.5, or an equivalent product. The tender also references CPV code 33690000-3, relating to miscellaneous medicinal preparations, indicating the nature of the control materials.

The procuring entity is the State Institution "Center for Public Health of the Ministry of Health of Ukraine." This acquisition is vital for maintaining high standards in diagnostic testing, supporting public health initiatives, and ensuring that laboratories can accurately detect HIV antibodies, contributing to effective disease surveillance and patient management within Ukraine.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals, Infectious Diseases and Laboratory. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 518,394.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.